These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 647686)
1. Cytocidal and cytostatic ability of Corynebacterium liquefaciens in mouse squamous cell carcinoma in vivo. Ando K; Urano M; Koike S Cancer Res; 1978 Jun; 38(6):1769-73. PubMed ID: 647686 [TBL] [Abstract][Full Text] [Related]
2. Effect of corynebacterium liquefaciens on a C3Hf mouse squamous cell carcinoma. Ando K; Urano M; Nesumi N; Koike S Cancer Res; 1977 Sep; 37(9):3115-9. PubMed ID: 884666 [TBL] [Abstract][Full Text] [Related]
3. Local control and disease-free survival after treatment of a squamous cell carcinoma by Corynebacterium parvum and local irradiation. Suit HD; Sedlacek R; Silobrcic V Cancer Res; 1977 Nov; 37(11):3869-75. PubMed ID: 908026 [No Abstract] [Full Text] [Related]
4. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response. Gordon WC; Prager MD Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275 [TBL] [Abstract][Full Text] [Related]
5. Successful immunotherapy with intraperitoneal Corynebacterium parvum in a murine ovarian cancer model is associated with the recruitment of tumor-lytic neutrophils into the peritoneal cavity. Lichtenstein AK; Kahle J; Berek J; Zighelboim J J Immunol; 1984 Jul; 133(1):519-26. PubMed ID: 6373934 [TBL] [Abstract][Full Text] [Related]
6. Immune RNA-mediated transfer of tumor antigen responsiveness to unresponsive peritoneal exudate cells from tumor-bearing animals. Braun DP; Dray S Cancer Res; 1977 Nov; 37(11):4138-44. PubMed ID: 908048 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness of neuraminidase in experimental immunotherapy of two murine pulmonary carcinomas. Alley CD; Snodgrass MJ Cancer Res; 1977 Jan; 37(1):95-101. PubMed ID: 830425 [TBL] [Abstract][Full Text] [Related]
8. Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies. Masui H; Kawamoto T; Sato JD; Wolf B; Sato G; Mendelsohn J Cancer Res; 1984 Mar; 44(3):1002-7. PubMed ID: 6318979 [TBL] [Abstract][Full Text] [Related]
9. Peritoneal cell populations during tumour injection. De Heer E; De Groot JW; Den Otter W; Dullens HF Int J Tissue React; 1982; 4(1):81-90. PubMed ID: 7085002 [TBL] [Abstract][Full Text] [Related]
10. Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude mice. Shalinsky DR; Bischoff ED; Gregory ML; Gottardis MM; Hayes JS; Lamph WW; Heyman RA; Shirley MA; Cooke TA; Davies PJ Cancer Res; 1995 Jul; 55(14):3183-91. PubMed ID: 7541715 [TBL] [Abstract][Full Text] [Related]
11. Cell kinetic studies of the cytostatic and cytocidal effect of 1-beta-D-arabinofuranosylcytosine on the L1210 ascites tumor. Fietkau R; Friede H; Maurer-Schultze B Cancer Res; 1984 Mar; 44(3):1105-13. PubMed ID: 6692397 [TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of macrophages induced by Corynebacterium liquefaciens. Suzuki T; Ishihara N; Seido T; Oboshi S Gan; 1977 Aug; 68(4):389-96. PubMed ID: 616415 [TBL] [Abstract][Full Text] [Related]
13. Quantitative transplantation assays of spontaneous tumors of the C3H mouse as allografts in athymic NCr/Sed-nu/nu nude mice and isografts in C3Hf/Sed mice. Suit HD; Sedlacek RS; Zietman A Cancer Res; 1988 Aug; 48(16):4525-8. PubMed ID: 3293775 [TBL] [Abstract][Full Text] [Related]
14. [Production of a cytotoxic factor in mouse peritoneal fluid by OK-432, a streptococcal preparation]. Yamamoto A; Nagamuta M; Usami H; Sugawara Y; Watanabe N; Niitsu Y; Urushizaki I Gan To Kagaku Ryoho; 1986 May; 13(5):1905-10. PubMed ID: 3707150 [TBL] [Abstract][Full Text] [Related]
15. Nonspecific stimulation of host defense by Corynebacterium kutscheri. I. Antitumor effect. Kita E; Nishikawa F; Yagyu Y; Hamuro A; Oku D; Emoto M; Katsui N; Tanikawa I; Kashiba S Nat Immun Cell Growth Regul; 1989; 8(6):313-24. PubMed ID: 2622460 [TBL] [Abstract][Full Text] [Related]
16. The distribution and persistence in vivo of Corynebacterium parvum in relation to its antitumor activity. Scott MT; Milas L Cancer Res; 1977 Jun; 37(6):1673-9. PubMed ID: 870181 [TBL] [Abstract][Full Text] [Related]
17. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression. Ji L; Fang B; Yen N; Fong K; Minna JD; Roth JA Cancer Res; 1999 Jul; 59(14):3333-9. PubMed ID: 10416589 [TBL] [Abstract][Full Text] [Related]
18. Transplantation of primary plasma cell tumor without 2,6,10,14- tetramethylpentadecane (pristane) treatment of the hosts. Platica M; Bojko C; Hollander VP Cancer Res; 1980 Mar; 40(3):579-81. PubMed ID: 7471077 [TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of Corynebacterium parvum and retinyl palmitate used in combination on the Lewis lung carcinoma. Pavelic ZP; Dave S; Bialkowski S; Priore RL; Greco WR Cancer Res; 1980 Dec; 40(12):4617-21. PubMed ID: 7438095 [TBL] [Abstract][Full Text] [Related]
20. Effect of Corynebacterium parvum on the response to irradiation of a C3H fibrosarcoma. Suit HD; Sedlacek R; Wagner M; Orsi L; Silobrcic V; Rothman KJ Cancer Res; 1976 Apr; 36(4):1305-14. PubMed ID: 1260756 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]